Business · Companies · 15 hrs ago
Boston Scientific unveils locally made Rezūm EVO device in China
Boston Scientific presented its Rezūm EVO device in China during the China International Import Expo.
The device is designed to treat benign prostate enlargement, a condition that can cause frequent or difficult urination in older men.
It delivers steam to enlarged prostate tissue through the urinary passage, without an external incision or permanent implant.
China is among the first markets to approve the device, according to the company.
The new model includes a touchscreen guide and features designed for use in outpatient and day-surgery settings.
Production is planned at the company’s Shanghai Lingang factory to supply the Chinese market.
The local production is part of the company’s effort to make the treatment more available in China.
Boston Scientific unveiled its locally made Rezūm EVO prostate treatment device at an event during the ninth China International Import Expo.
The device had already received approval from China’s National Medical Products Administration, and China is among its first approved markets globally.
Boston Scientific said the device will be produced at its Shanghai Lingang factory specifically for the Chinese market.
Rezūm uses steam delivered through the urethra to treat enlarged prostate tissue without an external incision or permanent implant.
- Who
- Boston Scientific unveiled the device, with company representatives and clinicians attending the event.
- What
- The company held a pre-launch event for its locally made Rezūm EVO device, a steam treatment for benign prostatic hyperplasia.
- When
- During the ninth China International Import Expo. The article was published on November 9, 2026.
- Where
- At the China International Import Expo in China; the device is planned for production at Boston Scientific’s Shanghai Lingang factory.
- Why
- Boston Scientific said local production is an important step in bringing the treatment to Chinese patients and increasing access to innovative therapies.
This story does not have two clearly opposing sides.
Rezūm EVO received approval from China’s National Medical Products Administration, making China one of its first approved markets globally.
Boston Scientific held a pre-launch event for the locally made Rezūm EVO device.
Rezūm EVO is scheduled to enter production at Boston Scientific’s Shanghai Lingang factory for supply to the Chinese market.
- Product
- Rezūm EVO prostate steam treatment device
- Approval
- China’s National Medical Products Administration
- Planned production site
- Shanghai Lingang factory
- Market
- Production is planned specifically for China
- Event
- Ninth China International Import Expo
1 source
What people are saying
Since Rezūm prostate steam therapy was introduced in China, Boston Scientific has been committed to making cutting-edge innovation better respond to the treatment needs of Chinese patients.